Clinical Trials List
Protocol NumberBH21260
Not yet recruiting
2008-10-15 - 2012-12-31
Phase IV
Terminated2
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- - - Division of Nephrology
- 高芷華 Division of Nephrology
- VIN-CENT Wu Division of Nephrology
- Jenq-Wen Huang Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 黃惠勇 Division of Nephrology
- Wen-Chin Lee Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
2800 participants
